Header image

Theme B Symposium Session 5: Screening

Tracks
.
Tuesday, September 25, 2018
4:30 PM - 6:00 PM
Doric (Ground Floor)

Details

Learning Objectives for session (expected outcomes): • Understand the range of screening instruments and interventions suitable for patients with HIV across their lifespan • Understand the limitations, both inherent and contextual, of current screening practices and instruments


Speaker

Mark Boyd

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in people living with HIV at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

4:30 PM - 4:50 PM

Audio Recording

Speaker Presentation

Biography

Agenda Item Image
Professor Richard Hillman
Senior Staff Specialist
HIV & Immunology, St Vincent's Hospital, Darlinghurstntre

Anal Cancer Screening - What are we Waiting For?

4:50 PM - 5:02 PM

Abstract

Audio Recording

Speaker Presentation

Biography

A/Prof Richard Hillman is a clinical researcher and sexual health physician with substantial expertise and experience in the delivery and evaluation of anal dysplasia screening and management programs. He was the lead Australian investigator in the male prophylactic HPV vaccination studies. He is currently Chief Clinical Investigator for SPANC, a number of AIN treatment trials and Australia’s first pilot anal cancer screening program. He runs the only Dysplasia and Anal Cancer Services (DACS) in NSW.
Assoc Professor Julia Brotherton
Public Health Physician, Medical Director of VCS Population Health
VCS Foundation

HPV and cervical screening

5:02 PM - 5:14 PM

Abstract

Audio Recording

Speaker Presentation

Biography

A/Prof Brotherton is a public health physician and epidemiologist with substantial expertise and experience in the delivery and evaluation of cervical screening and HPV vaccination programs. She was a lead investigator in Australian research demonstrating the world’s first evidence of declines in pre-cancerous cervical lesions post- vaccination.
A/PROF Lucette Cysique
Associate Professor
The University Of New South Wales

Neurocognitive screenings for HIV-associated neurocognitive disorders: An update

5:14 PM - 5:26 PM

Abstract

Audio Recording

Speaker Presentation

Biography

Dr Lucette Cysique is the NeuroHIV research group leader at Neuroscience Research Australia and UNSW Medicine. She conducts cross-disciplinary research into the neurocognitive changes associated with HIV, aging, HIV and cardio-vascular diseases, as well as their underpinnings in brain structural and metabolic changes using MRI/MRS/DTI and PET.
Agenda Item Image
Ms Ruth Hennessy
Head of Psychology / Senior Clinical Psychologist
The Albion Centre/SESLHD

Screening for Depression and Anxiety in HIV

5:26 PM - 5:38 PM

Audio Recording

Speaker Presentation

Biography

Ruth Hennessy is the Head of Psychology and Senior Clinical Psychologist at The Albion Centre. She has extensive experience in HIV psychological counselling and in training health care workers. She and the psychology team were recently part of the writing group for The Australian Standards for psychological support for adults with HIV.
Panel Discussion

Panellists: Claire Italiano, Jane Costello, Mark Boyd, Richard Hillman, Julia Brotherton, Lucette Cysique, Ruth Hennessey and Lance Feeney

5:38 PM - 6:00 PM

Biography


Chair

Jane Costello
Research and Program Manager
Kirby Institute, UNSW Sydney

Claire Italiano
Infectious Diseases Physician
Royal Perth Hospital

loading